Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report

Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report

Abstract Background Pembrolizumab is an immune-checkpoints inhibitor that enhances the immune response against cancer cells and therefore is useful for the treatment of several carcinomas. However, pembrolizumab sometimes perturbs the immune system resulting in various autoimmune neurological compli...

Full description

Bibliographic Details
Main Authors: Hikaru Kamo, Taku Hatano, Kazuaki Kanai, Nozomi Aoki, Daiki Kamiyama, Kazumasa Yokoyama, Masashi Takanashi, Yuri Yamashita, Yasushi Shimo, Nobutaka Hattori
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Neurology
Subjects:
Pembrolizumab
Necrotizing myositis
ICPIs-related systemic myositis
Ocular myositis
Immune-related adverse events
Myasthenia gravis
Online Access:http://link.springer.com/article/10.1186/s12883-019-1416-1

Internet

http://link.springer.com/article/10.1186/s12883-019-1416-1

Similar Items